State Street Corp Updates Passive Stake in Protagonist Therapeutics
Ticker: PTGX · Form: SC 13G/A · Filed: Jan 23, 2024 · CIK: 1377121
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**State Street still holds PTGX shares, no big changes, just an update.**
AI Summary
State Street Corp filed an amended SC 13G/A on January 23, 2024, indicating its ownership of Protagonist Therapeutics Inc (PTGX) common stock as of December 31, 2023. This filing is an update to their previous disclosures, confirming their continued significant, but passive, stake in the pharmaceutical company. This matters to investors as State Street is a major institutional investor, and their continued holding suggests a long-term, albeit passive, confidence in PTGX's prospects.
Why It Matters
This filing confirms State Street's ongoing, passive institutional investment in Protagonist Therapeutics, signaling continued confidence from a major financial player without indicating any intent to influence company management.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not signal any immediate risk or opportunity for the stock.
Analyst Insight
Investors should note that a major institutional investor like State Street continues to hold a position in Protagonist Therapeutics, which can be seen as a vote of confidence, but this filing itself doesn't suggest any immediate catalysts or changes in company direction.
Key Players & Entities
- State Street Corp (company) — the entity filing the SC 13G/A
- Protagonist Therapeutics, Inc (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 23, 2024 (date) — the date the SC 13G/A was filed
- 74366E102 (other) — CUSIP number for Protagonist Therapeutics Inc common stock
Forward-Looking Statements
- State Street Corp will maintain a passive investment strategy in Protagonist Therapeutics Inc. (State Street Corp) — high confidence, target: 2024-12-31
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, indicating a passive ownership stake.
Who is the reporting person in this filing?
The reporting person is State Street Corp, a state commercial bank based in Boston, MA.
What is the subject company whose securities are being reported?
The subject company is Protagonist Therapeutics, Inc, a pharmaceutical preparations company located in Newark, CA.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023.
Under which rule was this Schedule 13G/A filed?
This Schedule 13G/A was filed under Rule 13D-1 (B).
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 23, 2024 regarding Protagonist Therapeutics, Inc (PTGX).